Virtus ETF Advisers LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$110,805
-4.5%
125,062
+68.8%
0.06%
+26.1%
Q3 2022$116,000
-21.6%
74,087
+0.7%
0.05%
-16.4%
Q2 2022$148,000
+150.8%
73,547
+189.2%
0.06%
+111.5%
Q1 2022$59,000
-52.8%
25,427
-5.6%
0.03%
-44.7%
Q4 2021$125,000
-26.9%
26,928
+19.9%
0.05%
-37.3%
Q3 2021$171,000
-25.3%
22,465
-5.0%
0.08%
-20.2%
Q2 2021$229,000
-31.0%
23,646
-41.0%
0.09%
-32.9%
Q1 2021$332,000
+23.4%
40,100
+1.8%
0.14%
+25.0%
Q4 2020$269,000
-63.9%
39,387
-41.1%
0.11%
-71.4%
Q3 2020$745,000
+56.2%
66,851
-12.0%
0.39%
+73.0%
Q2 2020$477,000
+192.6%
75,984
-14.0%
0.23%
+237.3%
Q1 2020$163,000
-52.3%
88,342
-12.7%
0.07%
+19.6%
Q4 2019$342,000
+98.8%
101,216
+26.2%
0.06%
+60.0%
Q3 2019$172,000
-23.9%
80,214
-5.3%
0.04%
-27.1%
Q2 2019$226,000
-55.9%
84,682
-21.4%
0.05%
-95.6%
Q1 2019$512,000
+72.4%
107,761
-13.0%
1.09%
+2035.3%
Q4 2018$297,000
+7.6%
123,823
+97.5%
0.05%
+75.9%
Q3 2018$276,000
-64.8%
62,691
-42.3%
0.03%
-95.8%
Q2 2018$783,000
+150.2%
108,716
+168.8%
0.69%
+358.3%
Q3 2016$313,000
+38.5%
40,4380.0%0.15%
-10.1%
Q2 2016$226,000
+16.5%
40,438
+11.9%
0.17%
-37.1%
Q1 2016$194,00036,1300.27%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders